These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 31204721)

  • 1.
    Vlachou V; Larsen L; Pavlidou E; Ismayilova N; Mazarakis ND; Scala M; Pantazi M; Mankad K; Kinali M
    J Genet; 2019 Jun; 98(2):. PubMed ID: 31204721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Phenotype study of SCN2A gene related epilepsy].
    Zeng Q; Zhang YH; Yang XL; Zhang J; Liu AJ; Liu XY; Jiang YW; Wu XR
    Zhonghua Er Ke Za Zhi; 2018 Jul; 56(7):518-523. PubMed ID: 29996185
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical spectrum of SCN2A mutations expanding to Ohtahara syndrome.
    Nakamura K; Kato M; Osaka H; Yamashita S; Nakagawa E; Haginoya K; Tohyama J; Okuda M; Wada T; Shimakawa S; Imai K; Takeshita S; Ishiwata H; Lev D; Lerman-Sagie T; Cervantes-Barragán DE; Villarroel CE; Ohfu M; Writzl K; Gnidovec Strazisar B; Hirabayashi S; Chitayat D; Myles Reid D; Nishiyama K; Kodera H; Nakashima M; Tsurusaki Y; Miyake N; Hayasaka K; Matsumoto N; Saitsu H
    Neurology; 2013 Sep; 81(11):992-8. PubMed ID: 23935176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The therapeutic implication of a novel SCN2A mutation associated early-onset epileptic encephalopathy with Rett-like features.
    Liang JS; Lin LJ; Yang MT; Wang JS; Lu JF
    Brain Dev; 2017 Nov; 39(10):877-881. PubMed ID: 28709814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal SCN2A encephalopathy: A peculiar recognizable electroclinical sequence.
    Melikishvili G; Dulac O; Gataullina S
    Epilepsy Behav; 2020 Oct; 111():107187. PubMed ID: 32603808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unusual association of SCN2A epileptic encephalopathy with severe cortical dysplasia detected by prenatal MRI.
    Bernardo S; Marchionni E; Prudente S; De Liso P; Spalice A; Giancotti A; Manganaro L; Pizzuti A
    Eur J Paediatr Neurol; 2017 May; 21(3):587-590. PubMed ID: 28254201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SCN2A encephalopathy: A major cause of epilepsy of infancy with migrating focal seizures.
    Howell KB; McMahon JM; Carvill GL; Tambunan D; Mackay MT; Rodriguez-Casero V; Webster R; Clark D; Freeman JL; Calvert S; Olson HE; Mandelstam S; Poduri A; Mefford HC; Harvey AS; Scheffer IE
    Neurology; 2015 Sep; 85(11):958-66. PubMed ID: 26291284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paternal germline mosaicism of a SCN2A mutation results in Ohtahara syndrome in half siblings.
    Zerem A; Lev D; Blumkin L; Goldberg-Stern H; Michaeli-Yossef Y; Halevy A; Kivity S; Nakamura K; Matsumoto N; Leshinsky-Silver E; Saitsu H; Lerman-Sagie T
    Eur J Paediatr Neurol; 2014 Sep; 18(5):567-71. PubMed ID: 24814476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exome sequencing identifies a de novo SCN2A mutation in a patient with intractable seizures, severe intellectual disability, optic atrophy, muscular hypotonia, and brain abnormalities.
    Baasch AL; Hüning I; Gilissen C; Klepper J; Veltman JA; Gillessen-Kaesbach G; Hoischen A; Lohmann K
    Epilepsia; 2014 Apr; 55(4):e25-9. PubMed ID: 24579881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletions of SCN2A and SCN3A genes in a patient with West syndrome and autistic spectrum disorder.
    Chong PF; Saitsu H; Sakai Y; Imagi T; Nakamura R; Matsukura M; Matsumoto N; Kira R
    Seizure; 2018 Aug; 60():91-93. PubMed ID: 29929112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The phenotype and treatment of SCN2A-related developmental and epileptic encephalopathy.
    Kim HJ; Yang D; Kim SH; Kim B; Kim HD; Lee JS; Choi JR; Lee ST; Kang HC
    Epileptic Disord; 2020 Oct; 22(5):563-570. PubMed ID: 33000761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mutation in the neonatal isoform of SCN2A causes neonatal-onset epilepsy.
    Penkl A; Reunert J; Debus OM; Homann A; Och U; Rust S; Marquardt T
    Am J Med Genet A; 2022 Mar; 188(3):941-947. PubMed ID: 34874093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infantile epileptic encephalopathy, transient choreoathetotic movements, and hypersomnia due to a De Novo missense mutation in the SCN2A gene.
    Hackenberg A; Baumer A; Sticht H; Schmitt B; Kroell-Seger J; Wille D; Joset P; Papuc S; Rauch A; Plecko B
    Neuropediatrics; 2014 Aug; 45(4):261-4. PubMed ID: 24710820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SCN2A mutation in an infant presenting with migrating focal seizures and infantile spasm responsive to a ketogenic diet.
    Su DJ; Lu JF; Lin LJ; Liang JS; Hung KL
    Brain Dev; 2018 Sep; 40(8):724-727. PubMed ID: 29625812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opposing Effects on Na
    Ben-Shalom R; Keeshen CM; Berrios KN; An JY; Sanders SJ; Bender KJ
    Biol Psychiatry; 2017 Aug; 82(3):224-232. PubMed ID: 28256214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SCN2A mutation is associated with infantile spasms and bitemporal glucose hypometabolism.
    Sundaram SK; Chugani HT; Tiwari VN; Huq AH
    Pediatr Neurol; 2013 Jul; 49(1):46-9. PubMed ID: 23827426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders.
    Wolff M; Johannesen KM; Hedrich UBS; Masnada S; Rubboli G; Gardella E; Lesca G; Ville D; Milh M; Villard L; Afenjar A; Chantot-Bastaraud S; Mignot C; Lardennois C; Nava C; Schwarz N; Gérard M; Perrin L; Doummar D; Auvin S; Miranda MJ; Hempel M; Brilstra E; Knoers N; Verbeek N; van Kempen M; Braun KP; Mancini G; Biskup S; Hörtnagel K; Döcker M; Bast T; Loddenkemper T; Wong-Kisiel L; Baumeister FM; Fazeli W; Striano P; Dilena R; Fontana E; Zara F; Kurlemann G; Klepper J; Thoene JG; Arndt DH; Deconinck N; Schmitt-Mechelke T; Maier O; Muhle H; Wical B; Finetti C; Brückner R; Pietz J; Golla G; Jillella D; Linnet KM; Charles P; Moog U; Õiglane-Shlik E; Mantovani JF; Park K; Deprez M; Lederer D; Mary S; Scalais E; Selim L; Van Coster R; Lagae L; Nikanorova M; Hjalgrim H; Korenke GC; Trivisano M; Specchio N; Ceulemans B; Dorn T; Helbig KL; Hardies K; Stamberger H; de Jonghe P; Weckhuysen S; Lemke JR; Krägeloh-Mann I; Helbig I; Kluger G; Lerche H; Møller RS
    Brain; 2017 May; 140(5):1316-1336. PubMed ID: 28379373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic action potential clamp predicts functional separation in mild familial and severe de novo forms of
    Berecki G; Howell KB; Deerasooriya YH; Cilio MR; Oliva MK; Kaplan D; Scheffer IE; Berkovic SF; Petrou S
    Proc Natl Acad Sci U S A; 2018 Jun; 115(24):E5516-E5525. PubMed ID: 29844171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ketogenic diet as a successful early treatment modality for SCN2A mutation.
    Turkdogan D; Thomas G; Demirel B
    Brain Dev; 2019 Apr; 41(4):389-391. PubMed ID: 30415926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical and genetic spectrum of SCN2A gene associated epilepsy and episodic ataxia].
    Guan J; Du KX; Dong Y; Li L; Song PP; Gong H; Zhang XL; Jia TM
    Zhonghua Er Ke Za Zhi; 2022 Jan; 60(1):51-55. PubMed ID: 34986624
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.